Karin B Yeatts1, Steven J Lippmann2, Anna E Waller3, Kristen Hassmiller Lich4, Debbie Travers5, Morris Weinberger6, James F Donohue7. 1. Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill; Gillings School of Global Public Health, Center for Environmental Medicine, Asthma, and Lung Biology, University of North Carolina at Chapel Hill, Chapel Hill. Electronic address: Karin_Yeatts@unc.edu. 2. Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill; Carolina Center for Health Informatics, Department of Emergency Medicine, University of North Carolina at Chapel Hill, Chapel Hill. 3. Carolina Center for Health Informatics, Department of Emergency Medicine, University of North Carolina at Chapel Hill, Chapel Hill. 4. Department of Health Policy and Management, University of North Carolina at Chapel Hill, Chapel Hill. 5. Carolina Center for Health Informatics, Department of Emergency Medicine, University of North Carolina at Chapel Hill, Chapel Hill; School of Medicine, School of Nursing, University of North Carolina at Chapel Hill, Chapel Hill. 6. Department of Health Policy and Management, University of North Carolina at Chapel Hill, Chapel Hill; Center for Health Services Research in Primary Care, Durham VA Medical Center, Durham, NC. 7. Department of Pulmonary Diseases and Critical Care Medicine, University of North Carolina at Chapel Hill, Chapel Hill.
Abstract
BACKGROUND: Little is known about the population-based burden of ED care for COPD. METHODS: We analyzed statewide ED surveillance system data to quantify the frequency of COPD-related ED visits, hospital admissions, and comorbidities. RESULTS: In 2008 to 2009 in North Carolina, 97,511 COPD-related ED visits were made by adults ≥ 45 years of age, at an annual rate of 13.8 ED visits/1,000 person-years. Among patients with COPD (n = 33,799), 7% and 28% had a COPD-related return ED visit within a 30- and 365-day period of their index visit, respectively. Compared with patients on private insurance, Medicare, Medicaid, and noninsured patients were more likely to have a COPD-related return visit within 30 and 365 days and have three or more COPD-related visits within 365 days. There were no differences in return visits by sex. Fifty-one percent of patients with COPD were admitted to the hospital from the index ED visit. Subsequent hospital admission risk in the cohort increased with age, peaking at 65 to 69 years (risk ratio [RR], 1.41; 95% CI, 1.26-1.57); there was no difference by sex. Patients with congestive heart failure (RR, 1.29; 95% CI, 1.22-1.37), substance-related disorders (RR, 1.35; 95% CI, 1.13-1.60), or respiratory failure/supplemental oxygen (RR, 1.25; 95% CI, 1.19-1.31) were more likely to have a subsequent hospital admission compared with patients without these comorbidities. CONCLUSIONS: The population-based burden of COPD-related care in the ED is significant. Further research is needed to understand variations in COPD-related ED visits and hospital admissions.
BACKGROUND: Little is known about the population-based burden of ED care for COPD. METHODS: We analyzed statewide ED surveillance system data to quantify the frequency of COPD-related ED visits, hospital admissions, and comorbidities. RESULTS: In 2008 to 2009 in North Carolina, 97,511 COPD-related ED visits were made by adults ≥ 45 years of age, at an annual rate of 13.8 ED visits/1,000 person-years. Among patients with COPD (n = 33,799), 7% and 28% had a COPD-related return ED visit within a 30- and 365-day period of their index visit, respectively. Compared with patients on private insurance, Medicare, Medicaid, and noninsured patients were more likely to have a COPD-related return visit within 30 and 365 days and have three or more COPD-related visits within 365 days. There were no differences in return visits by sex. Fifty-one percent of patients with COPD were admitted to the hospital from the index ED visit. Subsequent hospital admission risk in the cohort increased with age, peaking at 65 to 69 years (risk ratio [RR], 1.41; 95% CI, 1.26-1.57); there was no difference by sex. Patients with congestive heart failure (RR, 1.29; 95% CI, 1.22-1.37), substance-related disorders (RR, 1.35; 95% CI, 1.13-1.60), or respiratory failure/supplemental oxygen (RR, 1.25; 95% CI, 1.19-1.31) were more likely to have a subsequent hospital admission compared with patients without these comorbidities. CONCLUSIONS: The population-based burden of COPD-related care in the ED is significant. Further research is needed to understand variations in COPD-related ED visits and hospital admissions.
Authors: Jørgen Vestbo; Suzanne S Hurd; Alvar G Agustí; Paul W Jones; Claus Vogelmeier; Antonio Anzueto; Peter J Barnes; Leonardo M Fabbri; Fernando J Martinez; Masaharu Nishimura; Robert A Stockley; Don D Sin; Roberto Rodriguez-Roisin Journal: Am J Respir Crit Care Med Date: 2012-08-09 Impact factor: 21.405
Authors: Louise Watson; Jorgen Vestbo; Dirkje S Postma; Marc Decramer; Stephen Rennard; Victor A Kiri; Paul A Vermeire; Joan B Soriano Journal: Respir Med Date: 2004-12 Impact factor: 3.415
Authors: Suellen M Curkendall; Cynthia DeLuise; Judith K Jones; Stephan Lanes; Mary Rose Stang; Earl Goehring; Dewei She Journal: Ann Epidemiol Date: 2005-07-21 Impact factor: 3.797
Authors: Christine R Jenkins; Dirkje S Postma; Antonio R Anzueto; Barry J Make; Stefan Peterson; Göran Eriksson; Peter M Calverley Journal: BMC Pulm Med Date: 2015-08-21 Impact factor: 3.317
Authors: Karla Diaz; Paola Faverio; Angela Hospenthal; Marcos I Restrepo; Megan E Amuan; Mary Jo V Pugh Journal: Ann Thorac Med Date: 2014-04 Impact factor: 2.219
Authors: Marjan Kerkhof; Jaco Voorham; Paul Dorinsky; Claudia Cabrera; Patrick Darken; Janwillem W H Kocks; Mohsen Sadatsafavi; Don D Sin; Victoria Carter; David B Price Journal: Int J Chron Obstruct Pulmon Dis Date: 2020-08-06
Authors: Chet D Schrader; Richard D Robinson; Somer Blair; Sajid Shaikh; James P d'Etienne; Jessica J Kirby; Radhika Cheeti; Nestor R Zenarosa; Hao Wang Journal: BMJ Open Date: 2019-06-27 Impact factor: 2.692